1. Home
  2. OCEAW vs CNOBP Comparison

OCEAW vs CNOBP Comparison

Compare OCEAW & CNOBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCEAW
  • CNOBP
  • Stock Information
  • Founded
  • OCEAW N/A
  • CNOBP N/A
  • Country
  • OCEAW United States
  • CNOBP United States
  • Employees
  • OCEAW 7
  • CNOBP 493
  • Industry
  • OCEAW Biotechnology: Pharmaceutical Preparations
  • CNOBP Major Banks
  • Sector
  • OCEAW Health Care
  • CNOBP Finance
  • Exchange
  • OCEAW Nasdaq
  • CNOBP Nasdaq
  • Market Cap
  • OCEAW N/A
  • CNOBP N/A
  • IPO Year
  • OCEAW 2021
  • CNOBP N/A
  • Fundamental
  • Price
  • OCEAW $0.02
  • CNOBP $22.87
  • Analyst Decision
  • OCEAW
  • CNOBP
  • Analyst Count
  • OCEAW 0
  • CNOBP 0
  • Target Price
  • OCEAW N/A
  • CNOBP N/A
  • AVG Volume (30 Days)
  • OCEAW N/A
  • CNOBP N/A
  • Earning Date
  • OCEAW N/A
  • CNOBP N/A
  • Dividend Yield
  • OCEAW N/A
  • CNOBP N/A
  • EPS Growth
  • OCEAW N/A
  • CNOBP N/A
  • EPS
  • OCEAW N/A
  • CNOBP N/A
  • Revenue
  • OCEAW N/A
  • CNOBP N/A
  • Revenue This Year
  • OCEAW N/A
  • CNOBP N/A
  • Revenue Next Year
  • OCEAW N/A
  • CNOBP N/A
  • P/E Ratio
  • OCEAW N/A
  • CNOBP N/A
  • Revenue Growth
  • OCEAW N/A
  • CNOBP N/A
  • 52 Week Low
  • OCEAW N/A
  • CNOBP N/A
  • 52 Week High
  • OCEAW N/A
  • CNOBP N/A
  • Technical
  • Relative Strength Index (RSI)
  • OCEAW N/A
  • CNOBP 35.63
  • Support Level
  • OCEAW N/A
  • CNOBP $22.55
  • Resistance Level
  • OCEAW N/A
  • CNOBP $23.20
  • Average True Range (ATR)
  • OCEAW 0.00
  • CNOBP 0.12
  • MACD
  • OCEAW 0.00
  • CNOBP -0.07
  • Stochastic Oscillator
  • OCEAW 0.00
  • CNOBP 7.46

About OCEAW Ocean Biomediacal Inc.

Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.

About CNOBP ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A

ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.

Share on Social Networks: